A phase 4, open-label, multicenter study of the safety and efficacy of agalsidase beta in Chinese patients with Fabry disease. - Ren, Hong; Zhang, Wei; Ouyang, Yan; Guo, Junhong; Xu, Hong; Ma, Jie; Luo, Xiaoping; Pan, Xiaoxia; Yuan, Yun; Shen, Qian; Li, Bin; Feng, Qiqi; et al. (Orphanet Journal of Rare Diseases, 2025)